Shares of Genpact Limited (NYSE:G – Get Free Report) have earned a consensus recommendation of “Hold” from the nine brokerages that are presently covering the company, Marketbeat Ratings reports. Eight investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $42.33.
A number of research firms have weighed in on G. Robert W. Baird upped their price objective on shares of Genpact from $44.00 to $48.00 and gave the company a “neutral” rating in a research report on Friday, November 8th. TD Cowen increased their price target on Genpact from $40.00 to $45.00 and gave the company a “hold” rating in a report on Friday, November 8th. Finally, Needham & Company LLC lifted their price objective on Genpact from $42.00 to $55.00 and gave the stock a “buy” rating in a report on Monday, November 11th.
Check Out Our Latest Analysis on Genpact
Genpact Price Performance
Genpact Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Monday, December 23rd. Shareholders of record on Monday, December 9th were paid a dividend of $0.1525 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $0.61 annualized dividend and a yield of 1.41%. Genpact’s payout ratio is 16.76%.
Insider Transactions at Genpact
In related news, CEO Balkrishan Kalra sold 13,600 shares of the company’s stock in a transaction on Friday, December 13th. The stock was sold at an average price of $44.60, for a total transaction of $606,560.00. Following the completion of the transaction, the chief executive officer now directly owns 267,404 shares in the company, valued at $11,926,218.40. This represents a 4.84 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In the last three months, insiders have sold 23,058 shares of company stock worth $1,044,715. 2.80% of the stock is currently owned by insiders.
Hedge Funds Weigh In On Genpact
Institutional investors have recently modified their holdings of the company. Birch Capital Management LLC raised its stake in Genpact by 22.4% during the 4th quarter. Birch Capital Management LLC now owns 114,082 shares of the business services provider’s stock valued at $4,900,000 after acquiring an additional 20,866 shares in the last quarter. Everence Capital Management Inc. acquired a new position in shares of Genpact during the fourth quarter valued at $210,000. GAMMA Investing LLC raised its stake in shares of Genpact by 55.7% during the fourth quarter. GAMMA Investing LLC now owns 5,183 shares of the business services provider’s stock valued at $223,000 after purchasing an additional 1,854 shares in the last quarter. Versant Capital Management Inc lifted its holdings in Genpact by 17.0% in the fourth quarter. Versant Capital Management Inc now owns 3,178 shares of the business services provider’s stock worth $136,000 after purchasing an additional 461 shares during the period. Finally, JPMorgan Chase & Co. grew its position in Genpact by 192.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider’s stock valued at $122,701,000 after buying an additional 2,060,595 shares in the last quarter. Institutional investors own 96.03% of the company’s stock.
About Genpact
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Read More
- Five stocks we like better than Genpact
- What is a Dividend King?
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- The Basics of Support and Resistance
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- What Are Some of the Best Large-Cap Stocks to Buy?
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.